http://researchonline.federation.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Report of the 3rd annual International Society of Hypertension New Investigator Symposium. http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:7659 Wed 07 Apr 2021 13:47:08 AEST ]]> Leading the change: Second International Society of Hypertension New Investigators' Symposium http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:5401 Wed 07 Apr 2021 13:45:02 AEST ]]> Council for high blood pressure research/InterAmerican Society of Hypertension/International Society of Hypertension: First new investigators symposium at the High Blood Pressure Research 2011 scientific sessions http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:4583 Wed 07 Apr 2021 13:44:04 AEST ]]> Report of the first International Society of Hypertension (ISH) Trainee/new investigator symposium : A global hypertension initiative http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:4523 Wed 07 Apr 2021 13:43:59 AEST ]]> ISH Hypertension Future Leaders Group : A network for new investigators run by new investigators http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:4256 Wed 07 Apr 2021 13:43:42 AEST ]]> May measurement month 2019 the global blood pressure screening campaign of the International Society of Hypertension http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14703 = 18 years) recruited through opportunistic sampling were screened at sites in 92 countries during May 2019. Ideally, 3 blood pressure readings were measured for each participant, and data on lifestyle factors and comorbidities were collected. Hypertension was defined as a systolic blood pressure >= 140 mm Hg, or a diastolic blood pressure >= 90 mm Hg (mean of the second and third readings) or taking antihypertensive medication. When necessary, multiple imputation was used to estimate participants' mean blood pressure. Mixed-effects models were used to evaluate associations between blood pressure and participant characteristics. Of 1 508 130 screenees 482 273 (32.0%) had never had a blood pressure measurement before and 513 337 (34.0%) had hypertension, of whom 58.7% were aware, and 54.7% were on antihypertensive medication. Of those on medication, 57.8% were controlled to <140/90 mm Hg, and 28.9% to <130/80 mm Hg. Of all those with hypertension, 31.7% were controlled to <140/90 mm Hg, and 350 825 (23.3%) participants had untreated or inadequately treated hypertension. Of those taking antihypertensive medication, half were taking only a single drug, and 25% reported using aspirin inappropriately. This survey is the largest ever synchronized and standardized contemporary compilation of global blood pressure data. This campaign is needed as a temporary substitute for systematic blood pressure screening in many countries worldwide.]]> Tue 19 Oct 2021 16:23:32 AEDT ]]> Renin-angiotensin system inhibitors in patients With COVID-19 : a meta-analysis of randomized controlled trials led by the International Society of Hypertension http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17626 Tue 09 May 2023 12:01:48 AEST ]]> Highlights from the International Society of Hypertension's New Investigators Network during 2019 http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14433 Thu 19 May 2022 12:14:45 AEST ]]> Addressing global disparities in blood pressure control : perspectives of the International Society of Hypertension http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:18147 Thu 03 Aug 2023 14:08:08 AEST ]]>